Clinical Trial Update: Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the immediate effects of combining ranibizumab (Lucentis) with verteporfin-based photodynamic therapy (Visudyne) in exudative age-relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED